Archive for: therapeutics

Plasma Protein Therapeutics Market to Reach $44,296.78 million, Globally, by 2031 at 5.2% CAGR: Allied Market Research

/ Business

 
 

Viking Therapeutics to start obesity drug mid-stage trial

/ US News

 
 

Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients

/ Business

 
 

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., Announces Record and Meeting Dates for its first Annual Meeting of Stockholders

/ Business

 
 

How Much Of F-star Therapeutics, Inc. (NASDAQ:FSTX) Do Institutions Own?

/ Business

 
 

Talaris Therapeutics Presents Additional Phase 2 Data and Analyses at American Transplant Congress 2022

/ Business

 
 

Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol

/ Business

 
 

Emergence Therapeutics raises €87 million Series A financing to advance Nectin-4 ADC

/ Business